VICKS ASSET SYNEX NASAL SPRAY 0.05% 15ML
VICKS ASSET SYNEX NASAL SPRAY 0.05% 15ML
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
100 ml of solution contain:
Active substance: Oxymetazoline hydrochloride 0.05 g
Excipients: sorbitol (70% aqueous solution) 5.0 g, sodium citrate dihydrate 0.875 g, tyloxapol 0.7 g, Chlorhexidine digluconate (20% solution) 0.27 g, anhydrous citric acid 0.2 g, aloe vera 0.1 g, benzalkonium chloride (50% solution) 0.04 g, levomenthol 0.015 g, potassium acesulfame 0.015 g, cineole 0.013 g, L-carvone 0.01 g, disodium edetate 0.01 g, sodium hydroxide (0.1 M solution) to pH 5.4, distilled water to 100 ml.
Bottle of 15 ml
Mechanism of action
Viks Active Sineks - a vasoconstrictor drug for local use in ENT practice
Oxymetazoline belongs to the group of alpha stimulants for topical use. Has a vasoconstrictor effect. With the introduction of intranasal reduces swelling of the mucous membrane of the upper respiratory tract, which leads to the relief of nasal breathing and the opening of the mouths of the paranasal sinuses and Eustachian tubes. The effect of the drug appears 5 minutes after application and lasts for 8-12 hours.
Indications and usage
For relief of nasal breathing in case of “cold” diseases or viral infections of the upper respiratory tract, sinusitis, rhinitis of any etiology.
- hypersensitivity to the drug;
- atrophic (dry) rhinitis;
- taking monoamine oxidase inhibitors (MAO) within the previous 2 weeks and within 2 weeks after their cancellation;
- angle-closure glaucoma;
- condition after transsphenoidal hypophysectomy;
- children's age up to 6 years;
- lactation period.
Carefully the drug should be used in patients suffering from diseases of the cardiovascular system (arterial hypertension, coronary heart disease, chronic heart failure, tachycardia, arrhythmias), carbohydrate metabolism (diabetes), thyroid function (hyperthyroidism), pheochromocytoma, chronic renal failure, prostatic hyperplasia (urinary retention) and taking tricyclic antidepressants and Bromocriptine.
Dosage and administration
Wix Active Synex is administered intranasally.
Adults and children over 10 years old - 1-2 injections into each nasal passage maximally 2-3 times a day.
Children from 6 to 10 years old - 1 injection in each nasal passage maximally 2-3 times a day.
Duration of treatment:
It is not recommended to use the drug for more than 7 days. With frequent or prolonged use of the drug, a feeling of difficulty in nasal breathing may recur or worsen. If these symptoms appear, you should stop treatment and consult a doctor.
When injecting, do not tilt the head backwards or spray in the prone position.
Sometimes burning or dryness of the mucous membranes of the nose, dryness in the mouth and throat, sneezing, an increase in the volume of secretions released from the nose. In rare cases, after the effect of using the drug has passed, a strong feeling of nasal congestion (reactive hyperemia).
Side effects caused by the systemic effect of the drug: increased blood pressure, headache, dizziness, heart palpitations, tachycardia, increased anxiety, sedation, irritability, sleep disturbances (in children), nausea, insomnia, exanthema, blurred vision (when getting into eyes ). Preservative benzalkoniya chloride, which is part of the drug, may be the cause of swelling of the nasal mucosa. If this happens, you need to change the drug to another, not containing preservatives.
In the recommended dose without consultation with the doctor, use no more than 7 days. If the symptoms worsen or the improvement does not occur within 3 days, you should consult with your doctor.
Avoid contact with eyes. To avoid the spread of infection, you must use the drug individually.
With simultaneous use with MAO inhibitors (including the period within 14 days after their cancellation) and tricyclic antidepressants, an increase in blood pressure may be observed. The drug slows down the absorption of local anesthetic drugs, lengthens their action. Co-administration of other vasoconstrictor drugs increases the risk of side effects.
Keep out of reach of children at a temperature not exceeding 25 ° C.